MariMed, Inc. (MRMD)
0.079
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
MariMed EPS Diluted (Quarterly) : -0.0117 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Stereotaxis, Inc. | -0.061 |
| Esperion Therapeutics, Inc. | 0.2173 |
| Silvergate Capital Corp. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.641M |
| Revenue (Quarterly) | 41.65M |
| Total Expenses (Quarterly) | 46.28M |
| Enterprise Value | 120.77M |
| Gross Profit Margin (Quarterly) | 9.00% |
| Profit Margin (Quarterly) | -11.14% |
| Earnings Yield | -46.33% |
| Normalized Earnings Yield | -45.32 |